Therapeutic Group: Anti Cancer Presentation Brigacent 90: Each film coated tablet contains Brigatinib INN 90 mg. Brigacent 180: Each film coated tablet contains Brigatinib INN 180 mg. Description Brigatinib is a potent and selective multi-targeted receptor tyrosine kinase inhibitor that blocks both anaplastic lymphoma kinase (ALK) and epidermal growth factor receptor (EGFR). Indications Brigatinib is […]